Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Roundhill Magnificent Seven ETF (MAGS) vs Tilray Brands Inc (TLRY) Price & Performance

Roundhill Magnificent Seven ETFTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Roundhill Magnificent Seven ETF vs Tilray Brands Inc — how do they compare? Roundhill Magnificent Seven ETF trades at $66.79, while Tilray Brands Inc trades at $4.25 (market cap $524.07M). The key difference: Roundhill Magnificent Seven ETF is trading nearer its 52-week high, Tilray Brands Inc nearer its low. Which is the better fit depends on your goals.

MAGSTLRY
Sector
Sector/ThematicHealth
52-Week High
$70.94$21.00
52-Week Low
$55.39$4.23
Market Cap
$524.07M
Enterprise Value
$621.22M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Roundhill Magnificent Seven ETF

MAGS (Roundhill Magnificent Seven ETF) trades at $66.93, showing minimal daily movement with a 0.03% gain. The ETF provides equal-weighted exposure to seven mega-cap tech stocks dominating AI-driven market returns. Technical indicators show mixed signals with bullish moving averages but neutral oscillators, while support and resistance cluster tightly around $66-68. Recent performance has been volatile, with the ETF dropping from its 2026 high of $71.17 amid sector rotation concerns.

The outlook hinges on AI adoption timelines and hyperscaler profitability. While MAGS delivered 181% returns since launch, concentration risk and high expectations create vulnerability if AI profits materialize slower than anticipated. Near-term performance depends on Q2 earnings broadening beyond semiconductors to Big Tech, with Morgan Stanley noting potential pivot opportunities. Current valuation compression in hyperscalers could present entry points if AI revenue outpaces infrastructure costs.

Tilray Brands Inc

TLRY trades at $4.23, down 1.63% on the day, with a bearish technical signal and negative earnings trends. The company reported a net loss of $2.19 billion in 2025 despite revenue growth to $821.31 million, reflecting deep profitability challenges. Analysts show cautious sentiment with 65% hold ratings, while recent news highlights expansion in medical cannabis and beverage segments amid ongoing regulatory uncertainty.

The outlook remains challenged by persistent losses and high debt-to-asset ratio of 12.25, though low P/S and P/B ratios suggest undervaluation. Key risks include profitability execution and federal cannabis policy shifts, while potential catalysts lie in international expansion and cost management improvements.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Roundhill Magnificent Seven ETF

MAGS is an ETF that provides concentrated exposure to the seven technology-focused mega-cap companies often referred to as the 'Magnificent Seven' (Alphabet, Amazon, Apple, Meta, Microsoft, NVIDIA, and Tesla). The fund is designed to capture the performance of these market-leading stocks, which have been the primary drivers of market returns. It offers a simple way for investors to invest solely in this select group of high-growth technology companies.

Read more on MAGS

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY